A 2-Log Reduction In Bcr-Abl/Abl Ratio In Cml-Cp Patients Achieving Complete Cytogenetic Response To Imatinib Predicts Durable Cytogenetic Remission.D Marin,A Franceschino,A Lennard,S O'Brien,J Byrne,G Smith,R Clark,P Shepherd, G Lucas,S Rule,J Goldman,J KaedaBLOOD(2003)引用 0|浏览9暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要